<author><surname>Bruno</surname> <given-names>JJ</given-names> </author><author><surname>Ellis</surname> <given-names>JJ</given-names> </author><title>Herbal use among US elderly: 2002 National Health Interview Survey</title><source>Ann Pharmacother</source><year>2005</year><volume>39</volume><fpage>643</fpage><lpage>648</lpage>
Slone Epidemiology Center<source>Patterns of Medication Use in the United States 2006. A Report from the Slone Survey</source><year>2006</year><other>Boston, Mass.</other><publisher>Slone Epidemiology Center at Boston University</publisher>
CDC<source>Incidence of Diagnosed Diabetes Per 1000 Population Aged 18&#8211;79 Years, by Sex and Age, United States, 1997&#8211;2005</source><year>2007</year><other>Atlanta, Georgia</other><publisher>Centers for Disease Control and Prevention (CDC)</publisher>Available at:
<author><surname>Marshall</surname> <given-names>S</given-names> </author><author><surname>Bacote</surname> <given-names>V</given-names> </author><author><surname>Traxinger</surname> <given-names>R</given-names> </author><title>Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance</title><source>J Biol Chem</source><year>1991</year><volume>266</volume><fpage>4706</fpage><lpage>4712</lpage>
<author><surname>Copeland</surname> <given-names>RJ</given-names> </author><author><surname>Bullen</surname> <given-names>JW</given-names> </author><author><surname>Hart</surname> <given-names>GW</given-names> </author><title>Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity</title><source>Am J Physiol Endocrinol Metab</source><year>2008</year><volume>295</volume><fpage>E17</fpage><lpage>E28</lpage>
<author><surname>Pham</surname> <given-names>T</given-names> </author><author><surname>Cornea</surname> <given-names>A</given-names> </author><author><surname>Blick</surname> <given-names>KE</given-names> </author><author><surname>Jenkins</surname> <given-names>A</given-names> </author><author><surname>Scofield</surname> <given-names>RH</given-names> </author><title>Oral glucosamine in doses used to treat osteoarthritis worsens insulin resistance</title><source>Am J Med Sci</source><year>2007</year><volume>333</volume><fpage>333</fpage><lpage>339</lpage>
<author><surname>Biggee</surname> <given-names>BA</given-names> </author><author><surname>Blinn</surname> <given-names>CM</given-names> </author><author><surname>Nuite</surname> <given-names>M</given-names> </author><author><surname>Silbert</surname> <given-names>JE</given-names> </author><author><surname>McAlindon</surname> <given-names>TE</given-names> </author><title>Effects of oral glucosamine sulphate on serum glucose and insulin during an oral glucose tolerance test of subjects with osteoarthritis</title><source>Ann Rheum Dis</source><year>2007</year><volume>66</volume><fpage>260</fpage><lpage>262</lpage>
<author><surname>Dahmer</surname> <given-names>S</given-names> </author><author><surname>Schiller</surname> <given-names>RM</given-names> </author><title>Glucosamine</title><source>Am Fam Physician</source><year>2008</year><volume>78</volume><fpage>471</fpage><lpage>476</lpage>
<author><surname>Shankar</surname> <given-names>RR</given-names> </author><author><surname>Zhu</surname> <given-names>J-S</given-names> </author><author><surname>Baron</surname> <given-names>AD</given-names> </author><title>Glucosamine infusion in rats mimics the beta-cell dysfunction of non-insulin-dependent diabetes mellitus</title><source>Metabolism</source><year>1998</year><volume>47</volume><fpage>573</fpage><lpage>577</lpage>
<author><surname>Muniyappa</surname> <given-names>R</given-names> </author><author><surname>Karne</surname> <given-names>RJ</given-names> </author><author><surname>Hall</surname> <given-names>G</given-names> </author><title>Oral glucosamine for 6 weeks at standard doses does not cause or worsen insulin resistance or endothelial dysfunction in lean or obese subjects</title><source>Diabetes</source><year>2006</year><volume>55</volume><fpage>3142</fpage><lpage>3150</lpage>
<author><surname>Quastel</surname> <given-names>JH</given-names> </author><title>Intestinal absorption of sugars and amino acids</title><source>Am J Clin Nutr</source><year>1960</year><volume>8</volume><fpage>137</fpage><lpage>146</lpage>
<author><surname>Hastings</surname> <given-names>TH</given-names> </author><author><surname>Landau</surname> <given-names>BR</given-names> </author><title>Specificity of sugar transport by the intestine of the hamster</title><source>Am J Physiol</source><year>1960</year><volume>198</volume><fpage>99</fpage><lpage>102</lpage>
<author><surname>Neale</surname> <given-names>RJ</given-names> </author><author><surname>Wiseman</surname> <given-names>G</given-names> </author><title>The use of dietary-restricted rat intestine for active transport studies</title><source>J Physiol</source><year>1969</year><volume>205</volume><fpage>159</fpage><lpage>178</lpage>
<author><surname>Faust</surname> <given-names>RG</given-names> </author><author><surname>Leadbetter</surname> <given-names>MG</given-names> </author><author><surname>Plenge</surname> <given-names>RK</given-names> </author><author><surname>McCaslin</surname> <given-names>AJ</given-names> </author><title>Active sugar transport by the small intestine. The effects of sugars, amino acids, hexosamines, sulfhydryl-reacting compounds, and cations on the preferential binding of D-glucose to tris-disrupted brush borders</title><source>J Gen Physiol</source><year>1968</year><volume>52</volume><fpage>482</fpage><lpage>494</lpage>
<author><surname>Hirayama</surname> <given-names>BA</given-names> </author><author><surname>Loo</surname> <given-names>DD</given-names> </author><author><surname>D&#237;ez-Sampedro</surname> <given-names>A</given-names> </author><title>Sodium-dependent reorganization of the sugar-binding site of SGLT1</title><source>Biochemistry</source><year>2007</year><volume>46</volume><fpage>13391</fpage><lpage>1406</lpage>
<author><surname>Roda</surname> <given-names>A</given-names> </author><author><surname>Sabatini</surname> <given-names>L</given-names> </author><author><surname>Barbieri</surname> <given-names>A</given-names> </author><title>Development and validation of a sensitive HPLC-ESI-MS/MS method for the direct determination of glucosamine in human plasma</title><source>J Chromatogr B</source><year>2006</year><volume>844</volume><fpage>119</fpage><lpage>126</lpage>
<author><surname>Biggee</surname> <given-names>BA</given-names> </author><author><surname>Blinn</surname> <given-names>CM</given-names> </author><author><surname>McAlindon</surname> <given-names>TE</given-names> </author><author><surname>Nuite</surname> <given-names>M</given-names> </author><author><surname>Silbert</surname> <given-names>JE</given-names> </author><title>Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness</title><source>Ann Rheum Dis</source><year>2006</year><volume>65</volume><fpage>222</fpage><lpage>226</lpage>
<author><surname>Persiani</surname> <given-names>S</given-names> </author><author><surname>Rotini</surname> <given-names>R</given-names> </author><author><surname>Trisolino</surname> <given-names>G</given-names> </author><title>Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose</title><source>Osteoarthritis Cartilage</source><year>2007</year><volume>15</volume><fpage>764</fpage><lpage>772</lpage>
<author><surname>Persiani</surname> <given-names>S</given-names> </author><author><surname>Roda</surname> <given-names>E</given-names> </author><author><surname>Rovati</surname> <given-names>LC</given-names> </author><author><surname>Locatelli</surname> <given-names>M</given-names> </author><author><surname>Giacovelli</surname> <given-names>G</given-names> </author><author><surname>Roda</surname> <given-names>A</given-names> </author><title>Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man</title><source>Osteoarthritis Cartilage</source><year>2005</year><volume>13</volume><fpage>1041</fpage><lpage>1049</lpage>
<author><surname>Setnikar</surname> <given-names>I</given-names> </author><author><surname>Rovati</surname> <given-names>LC</given-names> </author><title>Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review</title><source>Arzneimittelforschung</source><year>2001</year><volume>51</volume><fpage>699</fpage><lpage>725</lpage>
<author><surname>Adebowale</surname> <given-names>A</given-names> </author><author><surname>Du</surname> <given-names>J</given-names> </author><author><surname>Liang</surname> <given-names>Z</given-names> </author><author><surname>Leslie</surname> <given-names>JL</given-names> </author><author><surname>Eddington</surname> <given-names>ND</given-names> </author><title>The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs</title><source>Biopharm Drug Dispos</source><year>2002</year><volume>23</volume><fpage>217</fpage><lpage>225</lpage>
<author><surname>Du</surname> <given-names>J</given-names> </author><author><surname>White</surname> <given-names>N</given-names> </author><author><surname>Eddington</surname> <given-names>ND</given-names> </author><title>The bioavailability and pharmacokinetics of glucosamine hydrochloride and chondroitin sulfate after oral and intravenous single dose administration in the horse</title><source>Biopharm Drug Dispos</source><year>2004</year><volume>25</volume><fpage>109</fpage><lpage>116</lpage>
<author><surname>Laverty</surname> <given-names>S</given-names> </author><author><surname>Sandy</surname> <given-names>JD</given-names> </author><author><surname>Celeste</surname> <given-names>C</given-names> </author><author><surname>Vachon</surname> <given-names>P</given-names> </author><author><surname>Marier</surname> <given-names>J-F</given-names> </author><author><surname>Plaas</surname> <given-names>AH</given-names> </author><title>Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses</title><source>Arthritis Rheum</source><year>2005</year><volume>52</volume><fpage>181</fpage><lpage>191</lpage>
<author><surname>Aghazadeh-Habashi</surname> <given-names>A</given-names> </author><author><surname>Sattari</surname> <given-names>S</given-names> </author><author><surname>Pasutto</surname> <given-names>F</given-names> </author><author><surname>Jamali</surname> <given-names>F</given-names> </author><title>Single dose pharmacokinetics and bioavailability of glucosamine in the rat</title><source>J Pharm Pharm Sci</source><year>2002</year><volume>5</volume><fpage>181</fpage><lpage>184</lpage>
<author><surname>Setnikar</surname> <given-names>I</given-names> </author><author><surname>Palumbo</surname> <given-names>R</given-names> </author><author><surname>Canali</surname> <given-names>S</given-names> </author><author><surname>Zanolo</surname> <given-names>G</given-names> </author><title>Pharmacokinetics of glucosamine in man</title><source>Arzneimittelforschung</source><year>1993</year><volume>43</volume><fpage>1109</fpage><lpage>1113</lpage>
<author><surname>Aghazadeh-Habashi</surname> <given-names>A</given-names> </author><author><surname>Ibrahim</surname> <given-names>A</given-names> </author><author><surname>Carran</surname> <given-names>J</given-names> </author><author><surname>Anastassiades</surname> <given-names>T</given-names> </author><author><surname>Jamali</surname> <given-names>F</given-names> </author><title>Single dose pharmacokinetics and bioavailability of butyryl glucosamine in the rat</title><source>J Pharm Pharm Sci</source><year>2006</year><volume>9</volume><fpage>359</fpage><lpage>364</lpage>
<author><surname>Crociani</surname> <given-names>F</given-names> </author><author><surname>Alessandrini</surname> <given-names>A</given-names> </author><author><surname>Mucci</surname> <given-names>MM</given-names> </author><author><surname>Biavati</surname> <given-names>B</given-names> </author><title>Degradation of complex carbohydrates by Bifidobacterium spp</title><source>Int J Food Microbiol</source><year>1994</year><volume>24</volume><fpage>199</fpage><lpage>210</lpage>
<author><surname>Salyers</surname> <given-names>AA</given-names> </author><author><surname>Vercellotti</surname> <given-names>JR</given-names> </author><author><surname>West</surname> <given-names>SEH</given-names> </author><author><surname>Wilkins</surname> <given-names>TD</given-names> </author><title>Fermentation of mucin and plant polysaccharides by strains of bacteroides from the human colon</title><source>Appl Environ Microbiol</source><year>1977</year><volume>33</volume><fpage>319</fpage><lpage>322</lpage>
<author><surname>Kajinuma</surname> <given-names>H</given-names> </author><author><surname>Kuzuya</surname> <given-names>T</given-names> </author><author><surname>Ide</surname> <given-names>T</given-names> </author><author><surname>Tyler</surname> <given-names>JM</given-names> </author><title>Effects of glucosamine on insulin and glucagon secretion in dogs and ducks</title><source>Endocrinol Jpn</source><year>1975</year><volume>22</volume><fpage>517</fpage><lpage>523</lpage>
<author><surname>Giaccari</surname> <given-names>A</given-names> </author><author><surname>Morviducci</surname> <given-names>L</given-names> </author><author><surname>Zorretta</surname> <given-names>D</given-names> </author><title>In vivo effects of glucosamine on insulin secretion and insulin sensitivity in the rat: possible relevance to the maladaptive responses to chronic hyperglycaemia</title><source>Diabetologia</source><year>1995</year><volume>38</volume><fpage>518</fpage><lpage>524</lpage>
<author><surname>Baron</surname> <given-names>AD</given-names> </author><author><surname>Zhu</surname> <given-names>J-S</given-names> </author><author><surname>Zhu</surname> <given-names>J-H</given-names> </author><author><surname>Weldon</surname> <given-names>H</given-names> </author><author><surname>Maianu</surname> <given-names>L</given-names> </author><author><surname>Garvey</surname> <given-names>WT</given-names> </author><title>Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle: implications for glucose toxicity</title><source>J Clin Invest</source><year>1995</year><volume>96</volume><fpage>2792</fpage><lpage>2801</lpage>
<author><surname>Rossetti</surname> <given-names>L</given-names> </author><author><surname>Hawkins</surname> <given-names>M</given-names> </author><author><surname>Chen</surname> <given-names>W</given-names> </author><author><surname>Gindi</surname> <given-names>J</given-names> </author><author><surname>Barzilai</surname> <given-names>N</given-names> </author><title>In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats</title><source>J Clin Invest</source><year>1995</year><volume>96</volume><fpage>132</fpage><lpage>140</lpage>
<author><surname>Hawkins</surname> <given-names>M</given-names> </author><author><surname>Angelov</surname> <given-names>I</given-names> </author><author><surname>Liu</surname> <given-names>R</given-names> </author><author><surname>Barzilai</surname> <given-names>N</given-names> </author><author><surname>Rossetti</surname> <given-names>L</given-names> </author><title>The tissue concentration of UDP-N-acetylglucosamine modulates the stimulatory effect of insulin on skeletal muscle glucose uptake</title><source>J Biol Chem</source><year>1997</year><volume>272</volume><fpage>4889</fpage><lpage>4895</lpage>
<author><surname>Virkam&#228;ki</surname> <given-names>A</given-names> </author><author><surname>Daniels</surname> <given-names>MC</given-names> </author><author><surname>H&#228;mal&#228;inen</surname> <given-names>S</given-names> </author><author><surname>Utriainen</surname> <given-names>T</given-names> </author><author><surname>McClain</surname> <given-names>D</given-names> </author><author><surname>Yki-J&#228;rvinen</surname> <given-names>H</given-names> </author><title>Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues</title><source>Endocrinology</source><year>1997</year><volume>138</volume><fpage>2501</fpage><lpage>2507</lpage>
<author><surname>Holm&#228;ng</surname> <given-names>A</given-names> </author><author><surname>Nilsson</surname> <given-names>C</given-names> </author><author><surname>Niklasson</surname> <given-names>M</given-names> </author><author><surname>Larsson</surname> <given-names>BM</given-names> </author><author><surname>Lonroth</surname> <given-names>P</given-names> </author><title>Induction of insulin resistance by glucosamine reduces blood flow but not interstitial levels of either glucose or insulin</title><source>Diabetes</source><year>1999</year><volume>48</volume><fpage>106</fpage><lpage>111</lpage>
<author><surname>Kim</surname> <given-names>YB</given-names> </author><author><surname>Zhu</surname> <given-names>JS</given-names> </author><author><surname>Zierath</surname> <given-names>JR</given-names> </author><author><surname>Shen</surname> <given-names>HQ</given-names> </author><author><surname>Baron</surname> <given-names>AD</given-names> </author><author><surname>Kahn</surname> <given-names>BB</given-names> </author><title>Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle</title><source>Diabetes</source><year>1999</year><volume>48</volume><fpage>310</fpage><lpage>320</lpage>
<author><surname>Patti</surname> <given-names>ME</given-names> </author><author><surname>Virkamaki</surname> <given-names>A</given-names> </author><author><surname>Landaker</surname> <given-names>EJ</given-names> </author><author><surname>Kahn</surname> <given-names>CR</given-names> </author><author><surname>Yki-Jarvinen</surname> <given-names>H</given-names> </author><title>Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle</title><source>Diabetes</source><year>1999</year><volume>48</volume><fpage>1562</fpage><lpage>1571</lpage>
<author><surname>Spampinato</surname> <given-names>D</given-names> </author><author><surname>Giaccari</surname> <given-names>A</given-names> </author><author><surname>Trischitta</surname> <given-names>V</given-names> </author><title>Rats that are made insulin resistant by glucosamine treatment have impaired skeletal muscle insulin receptor phosphorylation</title><source>Metabolism</source><year>2003</year><volume>52</volume><fpage>1092</fpage><lpage>1095</lpage>
<author><surname>Robertson</surname> <given-names>MW</given-names> </author><author><surname>Dunshea</surname> <given-names>FR</given-names> </author><author><surname>Goddard</surname> <given-names>ME</given-names> </author><author><surname>Leury</surname> <given-names>BJ</given-names> </author><title>Stimulation of the hexosamine biosynthetic pathway by glucosamine in sheep</title><source>Asia Pac J Clin Nutr</source><year>2005</year><volume>14</volume><issue>suppl</issue><fpage>S79</fpage>
<author><surname>Monauni</surname> <given-names>T</given-names> </author><author><surname>Zenti</surname> <given-names>MG</given-names> </author><author><surname>Cretti</surname> <given-names>A</given-names> </author><title>Effects of glucosamine infusion on insulin secretion and insulin action in humans</title><source>Diabetes</source><year>2000</year><volume>49</volume><fpage>926</fpage><lpage>935</lpage>
<author><surname>Pouwels</surname> <given-names>M-J</given-names> </author><author><surname>Jacobs</surname> <given-names>JR</given-names> </author><author><surname>Span</surname> <given-names>PN</given-names> </author><author><surname>Lutterman</surname> <given-names>JA</given-names> </author><author><surname>Smits</surname> <given-names>P</given-names> </author><author><surname>Tack</surname> <given-names>CJ</given-names> </author><title>Short-term glucosamine infusion does not affect insulin sensitivity in humans</title><source>J Clin Endocrinol Metab</source><year>2001</year><volume>86</volume><fpage>2099</fpage><lpage>2103</lpage>
<author><surname>Oguchi</surname> <given-names>M</given-names> </author><author><surname>Miyatake</surname> <given-names>Y</given-names> </author><author><surname>Ayabe</surname> <given-names>J</given-names> </author><author><surname>Akamatsu</surname> <given-names>N</given-names> </author><title>Phosphorylation of D-glucosamine by rat liver glucokinase</title><source>J Biochem</source><year>1975</year><volume>77</volume><fpage>1117</fpage><lpage>1121</lpage>
<author><surname>Agius</surname> <given-names>L</given-names> </author><author><surname>Stubbs</surname> <given-names>M</given-names> </author><title>Investigation of the mechanism by which glucose analogues cause translocation of glucokinase in hepatocytes: evidence for two glucose binding sites</title><source>Biochem J</source><year>2000</year><volume>346</volume><fpage>413</fpage><lpage>421</lpage>
<author><surname>Albert</surname> <given-names>SG</given-names> </author><author><surname>Oiknine</surname> <given-names>RF</given-names> </author><author><surname>Parseghian</surname> <given-names>S</given-names> </author><author><surname>Mooradian</surname> <given-names>AD</given-names> </author><author><surname>Haas</surname> <given-names>MJ</given-names> </author><author><surname>McPherson</surname> <given-names>T</given-names> </author><title>The effect of glucosamine on serum HDL cholesterol and apolipoprotein AI levels in people with diabetes</title><source>Diabetes Care</source><year>2007</year><volume>30</volume><fpage>2800</fpage><lpage>2803</lpage>
<author><surname>Yu</surname> <given-names>JG</given-names> </author><author><surname>Boies</surname> <given-names>SM</given-names> </author><author><surname>Olefsky</surname> <given-names>JM</given-names> </author><title>The effect of oral glucosamine sulfate on insulin sensitivity in human subjects</title><source>Diabetes Care</source><year>2003</year><volume>26</volume><fpage>1941</fpage><lpage>1942</lpage>
<author><surname>Scroggie</surname> <given-names>DA</given-names> </author><author><surname>Albright</surname> <given-names>A</given-names> </author><author><surname>Harris</surname> <given-names>MD</given-names> </author><title>The effect of glucosamine-chondroitin supplementation on glycosylated hemoglobin levels in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial</title><source>Arch Intern Med</source><year>2003</year><volume>163</volume><fpage>1587</fpage><lpage>1590</lpage>
<author><surname>Tapadinhas</surname> <given-names>MJ</given-names> </author><author><surname>Rivera</surname> <given-names>IC</given-names> </author><author><surname>Bignamini</surname> <given-names>AA</given-names> </author><title>Oral glucosamine sulphate in the management of arthrosis: report on a multi-centre open investigation in Portugal</title><source>Pharmatherapeutica</source><year>1982</year><volume>3</volume><fpage>157</fpage><lpage>168</lpage>
<author><surname>Clegg</surname> <given-names>DO</given-names> </author><author><surname>Reda</surname> <given-names>DJ</given-names> </author><author><surname>Harris</surname> <given-names>CL</given-names> </author><title>Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis</title><source>N Engl J Med</source><year>2006</year><volume>354</volume><fpage>795</fpage><lpage>808</lpage>
<author><surname>Tannis</surname> <given-names>AJ</given-names> </author><author><surname>Barban</surname> <given-names>J</given-names> </author><author><surname>Conquer</surname> <given-names>JA</given-names> </author><title>Effect of glucosamine supplementation on fasting and non-fasting plasma glucose and serum insulin concentrations in healthy individuals</title><source>Osteoarthritis Cartilage</source><year>2004</year><volume>12</volume><fpage>506</fpage><lpage>511</lpage>
<author><surname>Hughes</surname> <given-names>R</given-names> </author><author><surname>Carr</surname> <given-names>A</given-names> </author><title>A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee</title><source>Rheumatology</source><year>2002</year><volume>41</volume><fpage>279</fpage><lpage>284</lpage>
<author><surname>Pavelk&#225;</surname> <given-names>K</given-names> </author><author><surname>Gatterova</surname> <given-names>J</given-names> </author><author><surname>Olejarova</surname> <given-names>M</given-names> </author><author><surname>Machacek</surname> <given-names>S</given-names> </author><author><surname>Giacovelli</surname> <given-names>G</given-names> </author><author><surname>Rovati</surname> <given-names>LC</given-names> </author><title>Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study</title><source>Arch Intern Med</source><year>2002</year><volume>162</volume><fpage>2113</fpage><lpage>2123</lpage>
<author><surname>Reginster</surname> <given-names>JY</given-names> </author><author><surname>Deroisy</surname> <given-names>R</given-names> </author><author><surname>Rovati</surname> <given-names>LC</given-names> </author><title>Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial</title><source>Lancet</source><year>2001</year><volume>357</volume><fpage>251</fpage><lpage>256</lpage>
<author><surname>Almada</surname> <given-names>AL</given-names> </author><author><surname>Harvey</surname> <given-names>P</given-names> </author><author><surname>Platt</surname> <given-names>K</given-names> </author><title>Effect of chronic oral glucosamine sulfate upon fasting insulin resistance index (FIRI) in non-diabetic individuals</title><source>FASEB J</source><year>2000</year><volume>14</volume><fpage>A750</fpage>[Abstract 521.15]
<author><surname>Giordano</surname> <given-names>N</given-names> </author><author><surname>Nardi</surname> <given-names>P</given-names> </author><author><surname>Senesi</surname> <given-names>M</given-names> </author><title>Efficacia e tollerabilit&#224; della glucosamina solfato nel trattamento della gonartrosi. [The efficacy and safety of glucosamine sulfate in the treatment of gonarthritis]</title><source>Clin Ter</source><year>1996</year><volume>147</volume><fpage>99</fpage><lpage>105</lpage>
<author><surname>Noack</surname> <given-names>W</given-names> </author><author><surname>Fischer</surname> <given-names>M</given-names> </author><author><surname>Forster</surname> <given-names>KK</given-names> </author><author><surname>Rovati</surname> <given-names>LC</given-names> </author><author><surname>Setnikar</surname> <given-names>I</given-names> </author><title>Glucosamine sulfate in osteoarthritis of the knee</title><source>Osteoarthritis Cartilage</source><year>1994</year><volume>2</volume><fpage>51</fpage><lpage>59</lpage>
<author><surname>D'Ambrosio</surname> <given-names>E</given-names> </author><author><surname>Casa</surname> <given-names>B</given-names> </author><author><surname>Bompani</surname> <given-names>R</given-names> </author><author><surname>Scali</surname> <given-names>G</given-names> </author><author><surname>Scali</surname> <given-names>M</given-names> </author><title>Glucosamine sulphate: a controlled clinical investigation in arthrosis</title><source>Pharmatherapeutica</source><year>1981</year><volume>2</volume><fpage>504</fpage><lpage>508</lpage>
<author><surname>Drovanti</surname> <given-names>A</given-names> </author><author><surname>Bignamini</surname> <given-names>AA</given-names> </author><author><surname>Rovati</surname> <given-names>AL</given-names> </author><title>Therapeutic activity of oral glucosamine sulfate in osteoarthrosis: a placebo-controlled double-blind investigation</title><source>Clin Ther</source><year>1980</year><volume>3</volume><fpage>260</fpage><lpage>272</lpage>
<author><surname>Crolle</surname> <given-names>G</given-names> </author><author><surname>D'Este</surname> <given-names>E</given-names> </author><title>Glucosamine sulphate for the management of arthrosis: a controlled clinical investigation</title><source>Curr Med Res Opin</source><year>1980</year><volume>7</volume><fpage>104</fpage><lpage>109</lpage>
<author><surname>Laferr&#232;re</surname> <given-names>B</given-names> </author><author><surname>Garcia-Lorda</surname> <given-names>P</given-names> </author><author><surname>Russell</surname> <given-names>CD</given-names> </author><author><surname>Pi-Sunyer</surname> <given-names>FX</given-names> </author><title>Effect of oral glucosamine sulfate on serum leptin levels in human subjects</title><source>Nutrition</source><year>2004</year><volume>20</volume><fpage>321</fpage><lpage>322</lpage>
<author><surname>Pujalte</surname> <given-names>JM</given-names> </author><author><surname>Llavore</surname> <given-names>EP</given-names> </author><author><surname>Ylescupidez</surname> <given-names>FR</given-names> </author><title>Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis</title><source>Curr Med Res Opin</source><year>1980</year><volume>7</volume><fpage>110</fpage><lpage>114</lpage>
<author><surname>Rovati</surname> <given-names>LC</given-names> </author><title>Clinical research in osteoarthritis: design and results of short-term and long-term with disease-modifying drugs</title><source>Int J Tissue React</source><year>1992</year><volume>14</volume><fpage>243</fpage><lpage>251</lpage>
<author><surname>Qiu</surname> <given-names>GX</given-names> </author><author><surname>Gao</surname> <given-names>SN</given-names> </author><author><surname>Giacovelli</surname> <given-names>G</given-names> </author><author><surname>Rovati</surname> <given-names>L</given-names> </author><author><surname>Setnikar</surname> <given-names>I</given-names> </author><title>Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis</title><source>Arzneimittelforschung</source><year>1998</year><volume>48</volume><fpage>469</fpage><lpage>474</lpage>
<author><surname>Valensi</surname> <given-names>P</given-names> </author><author><surname>Schwarz</surname> <given-names>EH</given-names> </author><author><surname>Hall</surname> <given-names>M</given-names> </author><author><surname>Felton</surname> <given-names>AM</given-names> </author><author><surname>Maldonato</surname> <given-names>A</given-names> </author><author><surname>Mathieu</surname> <given-names>C</given-names> </author><title>Pre-diabetes essential action: a European perspective</title><source>Diabetes Metab</source><year>2005</year><volume>31</volume><fpage>606</fpage><lpage>620</lpage>
IDF<title>Prevalence estimates of diabetes mellitus (DM), 2010</title><source>Diabetes Atlas: The e-Atlas</source><year>2010</year><issue>4th edn</issue><other>Brussels, Belgium</other><publisher>The International Diabetes Federation (IDF)</publisher>Available at:
EC<source>Population Statistics: Detailed Tables</source><year>2004</year><other>Luxembourg</other><publisher>Office for Official Publications of the European Communities</publisher>Available at:
<author><surname>Lee</surname> <given-names>YH</given-names> </author><author><surname>Woo</surname> <given-names>JH</given-names> </author><author><surname>Choi</surname> <given-names>SJ</given-names> </author><author><surname>Ji</surname> <given-names>JD</given-names> </author><author><surname>Song</surname> <given-names>GG</given-names> </author><title>Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis</title><source>Rheumatol Int</source><year>2010</year><volume>30</volume><fpage>357</fpage><lpage>363</lpage>
<author><surname>Marshall</surname> <given-names>S</given-names> </author><author><surname>Nadeau</surname> <given-names>O</given-names> </author><author><surname>Yamasaki</surname> <given-names>K</given-names> </author><title>Dynamic actions of glucose and glucosamine on hexosamine biosynthesis in isolated adipocytes: differential effects on glucosamine 6-phosphate, UDP-N-acetylglucosamine, and ATP levels</title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>35313</fpage><lpage>35319</lpage>
<author><surname>Heart</surname> <given-names>E</given-names> </author><author><surname>Choi</surname> <given-names>WS</given-names> </author><author><surname>Sung</surname> <given-names>CK</given-names> </author><title>Glucosamine-induced insulin resistance in 3T3-L1 adipocytes</title><source>Am J Physiol Endocrinol Metab</source><year>2000</year><volume>278</volume><fpage>E103</fpage><lpage>E112</lpage>
<author><surname>Echard</surname> <given-names>BW</given-names> </author><author><surname>Talpur</surname> <given-names>NA</given-names> </author><author><surname>Funk</surname> <given-names>KA</given-names> </author><author><surname>Bagchi</surname> <given-names>D</given-names> </author><author><surname>Preuss</surname> <given-names>HG</given-names> </author><title>Effects of oral glucosamine and chondroitin sulfate alone and in combination on the metabolism of SHR and SD rats</title><source>Mol Cell Biochem</source><year>2001</year><volume>225</volume><fpage>85</fpage><lpage>91</lpage>
<author><surname>McNamara</surname> <given-names>PS</given-names> </author><author><surname>Barr</surname> <given-names>SC</given-names> </author><author><surname>Erb</surname> <given-names>HN</given-names> </author><title>Hematologic, hemostatic, and biochemical effects in dogs receiving an oral chondroprotective agent for thirty days</title><source>Am J Vet Res</source><year>1996</year><volume>57</volume><fpage>1390</fpage><lpage>1394</lpage>
<author><surname>Stender</surname> <given-names>S</given-names> </author><author><surname>Astrup</surname> <given-names>P</given-names> </author><title>Glucosamine and experimental atherosclerosis. Increased wet weight and charged composition of cholesterol fatty acids in aorta of rabbits fed a cholesterol-enriched diet with added glucosamine</title><source>Atherosclerosis</source><year>1977</year><volume>26</volume><fpage>205</fpage><lpage>213</lpage>